Castration Resistant Prostate Cancer Treatment Market Size & Share Analysis 2032 According to a newly published market research report by 24LifeSciences, global castration resistant prostate cancer (CRPC) treatment market was valued at USD 8.42 billion in 2024 and is projected to reach USD 14.93 billion by 2032, growing at a compound annual growth rate (CAGR) of 7,3% during the forecast period 2025-2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15952/castration-resistant-prostate-cancer-treatment-market